Cargando…

Intrathecal kappa free light chains as markers for multiple sclerosis

Cerebrospinal fluid (CSF) kappa free light chain (KFLC) index has been described as a reliable marker of intrathecal IgG synthesis to diagnose multiple sclerosis (MS). Our aims were: (1) to compare the efficiency of KFLC through different interpretation approaches in diagnosing MS. (2) to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vecchio, D., Bellomo, G., Serino, R., Virgilio, E., Lamonaca, M., Dianzani, U., Cantello, R., Comi, C., Crespi, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683527/ https://www.ncbi.nlm.nih.gov/pubmed/33230241 http://dx.doi.org/10.1038/s41598-020-77029-7

Ejemplares similares

K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up
por: Crespi, Ilaria, et al.
Publicado: (2019)

Serum Vitamin D as a Marker of Impaired Information Processing Speed and Early Disability in Multiple Sclerosis Patients
por: Virgilio, Eleonora, et al.
Publicado: (2021)

Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020)

Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
por: Arneth, Borros, et al.
Publicado: (2022)

Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment
por: Süße, Marie, et al.
Publicado: (2022)

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
por: Natali, Patrizia, et al.
Publicado: (2022)

The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes
por: Bertram, Dominic, et al.
Publicado: (2023)

Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis
por: Passerini, Gabriella, et al.
Publicado: (2016)

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2021)

Evidence for an Intrathecal Immunoglobulin Synthesis by Kappa Free Light Chains in Neurological Patients with an Isolated Band in Isoelectric Focusing
por: Weiss, Bastian, et al.
Publicado: (2022)

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
por: Castillo-Villalba, Jéssica, et al.
Publicado: (2022)

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity
por: Berek, Klaus, et al.
Publicado: (2021)

Kappa free light chains index in multiple sclerosis very long-term prognosis
por: Arroyo-Pereiro, Pablo, et al.
Publicado: (2023)

Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis
por: Virgilio, Eleonora, et al.
Publicado: (2023)

Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis
por: Vecchio, Domizia, et al.
Publicado: (2023)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
por: Hegen, Harald, et al.
Publicado: (2022)

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2018)

Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis
por: Menéndez-Valladares, P, et al.
Publicado: (2015)

Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy
por: Kleeberg, L, et al.
Publicado: (2009)

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study
por: Hegen, Harald, et al.
Publicado: (2023)

Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
por: Hegen, Harald, et al.
Publicado: (2022)

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis
por: Hegen, Harald, et al.
Publicado: (2022)

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
por: Levraut, Michael, et al.
Publicado: (2022)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
por: Monreal, Enric, et al.
Publicado: (2023)

Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS
por: Presslauer, Stefan, et al.
Publicado: (2014)

The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation
por: Konen, Franz Felix, et al.
Publicado: (2020)

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
por: Virgilio, Eleonora, et al.
Publicado: (2022)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018)

Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy
por: Süße, Marie, et al.
Publicado: (2020)

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid
por: Konen, Franz F, et al.
Publicado: (2021)

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Susac Syndrome: an uncommon cause of impaired vision
por: Barbero, Paolo, et al.
Publicado: (2022)

Kappa light-chain amyloidosis of gastrointestinal tract
por: Hashimoto, Rintaro, et al.
Publicado: (2019)

Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases
por: Konen, Franz Felix, et al.
Publicado: (2022)

A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF Analysis
por: Hannich, Malte Johannes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_skmeca6b6rsadi4lgdn9s8trpq